Award Description
The recipient of this award is a pre-commercialized company recognized for their potential. Through technology advances and business milestones, these companies will have contributed to the Canadian biotech landscape.
Past Award Recipients
- 2023 – Abdera Therapeutics
- 2022 – Inversago Pharma
- 2018 – Aspect Biosystems Ltd.
- 2017 – Turnstone Biologics
- 2016 – Northern Biologics
- 2015 – Zymeworks
- 2014 – Trillium Therapeutics
- 2013 – Aquinox Pharmaceuticals Inc.
- 2012 – Therapure Biopharma Inc.
- 2011 – Allon Therapeutics Inc.
- 2010 – iCo Therapeutics Inc.
- 2009 – Medicago Inc.
- 2008 – Xenon Pharmaceuticals*
- 2007 – Chemaphor Inc.
- 2006 – Rimon Therapeutics Ltd.
- 2005 – ImmunoVaccine Technologies Inc., Halifax, NS
- 2005 – Trillium Therapeutics Inc., Toronto, ON
- 2004 – Arc Pharmaceuticals Inc, Vancouver, BC
- 2004 – Clera Inc., Toronto, ON
- 2004 – Generex Biotechnology, Toronto, ON
- 2003 – GB Therapeutics (now CITA Neuropharma Inc.), Mississauga, ON
- 2003 – Zelos Therapeutics, Ottawa, ON
- 2003 – Zinc Therapeutics, Toronto, ON
*Prior to 2008, BIOTECanada’s annual awards program was known as the National Biotechnology Awards with recognition for companies and this award was called “Promising Early Stage company(s) Recognition”.